Cost-Effectiveness and Cost-Utility Analysis of Treat-to-Target Versus Usual Care in Early Rheumatoid Arthritis: Results of the DREAM Registry

M. Vermeer, Wietske Kievit, Ina H. Kuper, Louise Marie Antoinette Braakman-Jansen, Hein J. Bernelot Moens, Theo R. Zijlstra, Alfons A. den Broeder, P.L. van Riel, Jaap Fransen, Mart A F J van de Laar

    Research output: Other contributionOther research output

    Original languageUndefined
    Place of PublicationBerlijn, Duitsland
    Publication statusPublished - 6 Jun 2012

    Keywords

    • METIS-291249

    Cite this